Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 03, 2009 Filed Nov 6, 2009 00:01 UTC |
Kuhlik Bruce NExec. V.P. and General Counsel
|
GrantStock Option (right to buy) · Derivative | 62,400 | $0.00 Strike: $44.30 | $0.00 |
DisclosureSEC source: 0001209191-09-051303 · c92125_4x0.xml · derivative · entry 13 Kuhlik Bruce N · CIK 0001408181 · Exec. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,400 shares Expires 2018-02-28 F3 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F3 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:01 UTC |
Kuhlik Bruce NExec. V.P. and General Counsel
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $51.02 | $0.00 |
DisclosureSEC source: 0001209191-09-051303 · c92125_4x0.xml · derivative · entry 12 Kuhlik Bruce N · CIK 0001408181 · Exec. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2017-07-31 F3 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F3 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:01 UTC |
Kuhlik Bruce NExec. V.P. and General Counsel
|
GrantStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-09-051303 · c92125_4x0.xml · derivative · entry 11 Kuhlik Bruce N · CIK 0001408181 · Exec. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2017-03-01 F3 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F3 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:01 UTC |
Kuhlik Bruce NExec. V.P. and General Counsel
|
GrantStock Option (right to buy) · Derivative | 20,880 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001209191-09-051303 · c92125_4x0.xml · derivative · entry 10 Kuhlik Bruce N · CIK 0001408181 · Exec. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,880 shares Expires 2016-03-02 F3 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F3 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:01 UTC |
Kuhlik Bruce NExec. V.P. and General Counsel
|
GrantStock Option (right to buy) · Derivative | 500 | $0.00 Strike: $34.47 | $0.00 |
DisclosureSEC source: 0001209191-09-051303 · c92125_4x0.xml · derivative · entry 9 Kuhlik Bruce N · CIK 0001408181 · Exec. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2016-01-31 F3 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F3 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:01 UTC |
Kuhlik Bruce NExec. V.P. and General Counsel
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $32.72 | $0.00 |
DisclosureSEC source: 0001209191-09-051303 · c92125_4x0.xml · derivative · entry 8 Kuhlik Bruce N · CIK 0001408181 · Exec. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2015-05-22 F3 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F3 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:01 UTC |
Kuhlik Bruce NExec. V.P. and General Counsel
|
GrantRSU - Leader Shares · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051303 · c92125_4x0.xml · derivative · entry 7 Kuhlik Bruce N · CIK 0001408181 · Exec. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2011-02-28 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:01 UTC |
Kuhlik Bruce NExec. V.P. and General Counsel
|
GrantRSU - Leader Shares · Derivative | 3,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051303 · c92125_4x0.xml · derivative · entry 6 Kuhlik Bruce N · CIK 0001408181 · Exec. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,700 shares Expires 2010-02-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:01 UTC |
Kuhlik Bruce NExec. V.P. and General Counsel
|
GrantRestricted Stock Unit · Derivative | 13,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051303 · c92125_4x0.xml · derivative · entry 5 Kuhlik Bruce N · CIK 0001408181 · Exec. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,650 shares Expires 2012-04-24 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:01 UTC |
Kuhlik Bruce NExec. V.P. and General Counsel
|
GrantRestricted Stock Unit · Derivative | 11,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051303 · c92125_4x0.xml · derivative · entry 4 Kuhlik Bruce N · CIK 0001408181 · Exec. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,700 shares Expires 2011-02-28 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:01 UTC |
Kuhlik Bruce NExec. V.P. and General Counsel
|
GrantRestricted Stock Unit · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051303 · c92125_4x0.xml · derivative · entry 3 Kuhlik Bruce N · CIK 0001408181 · Exec. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2010-08-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:01 UTC |
Kuhlik Bruce NExec. V.P. and General Counsel
|
GrantRestricted Stock Unit · Derivative | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051303 · c92125_4x0.xml · derivative · entry 2 Kuhlik Bruce N · CIK 0001408181 · Exec. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,500 shares Expires 2010-03-02 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:01 UTC |
Kuhlik Bruce NExec. V.P. and General Counsel
|
GrantCommon Stock | 17,660.0888 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051303 · c92125_4x0.xml · nonDerivative · entry 1 Kuhlik Bruce N · CIK 0001408181 · Exec. V.P. and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions"). Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantStock Option (right to buy) · Derivative | 30,800 | $0.00 Strike: $23.45 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 19 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,800 shares Expires 2019-04-23 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantStock Option (right to buy) · Derivative | 26,400 | $0.00 Strike: $44.30 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 18 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,400 shares Expires 2018-02-28 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 17 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2017-03-01 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 16 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,000 shares Expires 2016-03-02 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $34.47 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 15 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2016-01-31 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantStock Option (right to buy) · Derivative | 15,825 | $0.00 Strike: $75.76 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 14 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,825 shares Expires 2011-03-01 F5 · price: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 13 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2015-02-24 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $28.90 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 12 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2014-10-31 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $48.24 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 11 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2014-02-26 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantStock Option (right to buy) · Derivative | 12,660 | $0.00 Strike: $62.09 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 10 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,660 shares Expires 2010-02-21 F5 · price: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantStock Option (right to buy) · Derivative | 3,165 | $0.00 Strike: $51.47 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 9 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,165 shares Expires 2013-07-31 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantStock Option (right to buy) · Derivative | 18,990 | $0.00 Strike: $49.96 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 8 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,990 shares Expires 2013-02-27 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantStock Option (right to buy) · Derivative | 15,825 | $0.00 Strike: $58.91 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 7 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,825 shares Expires 2012-02-29 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantRestricted Stock Unit · Derivative | 9,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 6 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,681 shares Expires 2012-07-24 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantRestricted Stock Unit · Derivative | 5,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 5 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,775 shares Expires 2012-04-24 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantRestricted Stock Unit · Derivative | 4,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 4 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,950 shares Expires 2011-02-28 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantRestricted Stock Unit · Derivative | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · derivative · entry 3 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2010-03-02 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
OtherCommon Stock - 401(k) Plan | 2,400.7973 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · nonDerivative · entry 2 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 0 F2 · price: Received as part of the Transactions in exchange for an equivalent number of shares of MSD common stock held under the MSD 401(k) plan. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:04 UTC |
Canan JohnSenior V-P, Controller
|
GrantCommon Stock | 7,477.5705 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051304 · c92127_4x0.xml · nonDerivative · entry 1 Canan John · CIK 0001374366 · Senior V-P, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions"). Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
GrantStock Option (right to buy) · Derivative | 62,400 | $0.00 Strike: $23.45 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 14 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,400 shares Expires 2019-04-23 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $44.30 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 13 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,000 shares Expires 2018-02-28 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
GrantStock Option (right to buy) · Derivative | 40,800 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 12 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,800 shares Expires 2017-03-01 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
GrantStock Option (right to buy) · Derivative | 36,000 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 11 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2016-03-02 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 10 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2015-02-24 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
GrantStock Option (right to buy) · Derivative | 21,750 | $0.00 Strike: $48.24 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 9 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,750 shares Expires 2014-02-26 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
GrantStock Option (right to buy) · Derivative | 42,200 | $0.00 Strike: $55.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 8 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,200 shares Expires 2013-04-30 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
GrantStock Option (right to buy) · Derivative | 31,650 | $0.00 Strike: $52.28 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 7 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,650 shares Expires 2013-03-24 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
GrantRSU - Leader Shares · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 6 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2012-04-24 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
GrantRestricted Stock Unit · Derivative | 11,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 5 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,700 shares Expires 2012-04-24 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
GrantRestricted Stock Unit · Derivative | 9,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 4 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,750 shares Expires 2011-02-28 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
GrantRestricted Stock Unit · Derivative | 7,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 3 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,650 shares Expires 2010-03-02 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
OtherCommon Stock - 401(k) Plan | 2,608.7358 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · nonDerivative · entry 2 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 0 F2 · price: Received as part of the Transactions in exchange for an equivalent number of shares of MSD common stock held under the MSD 401(k) plan. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC |
Scalet J ChrisExe. VP, Global Services & CIO
|
GrantCommon Stock | 26,167.8585 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · nonDerivative · entry 1 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions"). Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantStock Option (right to buy) · Derivative | 280,000 | $0.00 Strike: $23.45 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · derivative · entry 15 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 280,000 shares Expires 2019-04-23 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantStock Option (right to buy) · Derivative | 252,000 | $0.00 Strike: $44.30 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · derivative · entry 14 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 252,000 shares Expires 2018-02-28 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $51.02 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · derivative · entry 13 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2017-07-31 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantStock Option (right to buy) · Derivative | 131,040 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · derivative · entry 12 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 131,040 shares Expires 2017-03-01 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.